141 related articles for article (PubMed ID: 7209108)
21. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
22. Total urinary hydroxyproline excretion before and after hypophysectomy in patients with bone metastases from breast carcinoma.
Ditzel J; Jordal R; Riskaer N
Acta Endocrinol (Copenh); 1968 Nov; 59(3):353-61. PubMed ID: 5754976
[No Abstract] [Full Text] [Related]
23. Alpha CTX as a biomarker of skeletal invasion of breast cancer: immunolocalization and the load dependency of urinary excretion.
Leeming DJ; Delling G; Koizumi M; Henriksen K; Karsdal MA; Li B; Qvist P; Tankó LB; Byrjalsen I
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1392-5. PubMed ID: 16835341
[TBL] [Abstract][Full Text] [Related]
24. [Urinary polyamines and hydroxyproline in patients with breast cancer].
Solov'ev IE; Iurzhenko NN
Vrach Delo; 1986 Jun; (6):80-4. PubMed ID: 3750970
[No Abstract] [Full Text] [Related]
25. The significance of hydroxyprolinuia for the proof of bone metastases of tumours.
Mirejovská E; Beska F; Pitronová M
Neoplasma; 1968; 15(4):433-8. PubMed ID: 5684467
[No Abstract] [Full Text] [Related]
26. Urinary hydroxyproline, serum alkaline phosphatase, calcium and phosphorus in patients with bone neoplasms.
Radom S; Zulawski M; Golebiowska D
Pol Med J; 1972; 11(4):809-14. PubMed ID: 4342776
[No Abstract] [Full Text] [Related]
27. Biochemical picture of bone metabolism in breast cancer patients with bone metastases.
Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A
Anticancer Res; 1995; 15(6B):2871-5. PubMed ID: 8669881
[TBL] [Abstract][Full Text] [Related]
28. Urinary hydroxyproline in the management of breast cancer.
Cuschieri A
World J Surg; 1977 May; 1(3):299-302. PubMed ID: 883324
[No Abstract] [Full Text] [Related]
29. Total, dialyzable, and nondialyzable postabsorptive hydroxyproline. Values in patients with cancer.
Niell HB; Palmieri GM; Neely CL; Maxwell TA; Hopkins SC; Soloway MS
Arch Intern Med; 1983 Oct; 143(10):1925-7. PubMed ID: 6625779
[TBL] [Abstract][Full Text] [Related]
30. Hydroxyproline excretion in patients with breast cancer and response to treatment.
Powles TJ; Leese CL; Bondy PK
Br Med J; 1975 Apr; 2(5964):164-6. PubMed ID: 1125725
[TBL] [Abstract][Full Text] [Related]
31. Procollagen type I carboxy-terminal propeptide as a marker of osteoblastic bone metastases.
Francini G; Gonnelli S; Petrioli R; Bruni S; Marsili S; Aquino A; Camporeale A
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):125-9. PubMed ID: 8467247
[TBL] [Abstract][Full Text] [Related]
32. [Hydroxyprolinuria and bone metastases of breast cancer].
Cruciani G; Bardella D; Fiorentini GM; Marangolo M; Tavolazzi L
Tumori; 1980 Apr; 66(2):205-13. PubMed ID: 7445102
[TBL] [Abstract][Full Text] [Related]
33. The postabsorptive hydroxyproline in the long-term evaluation of patients with breast cancer.
Niell HB; Neely CL; Palmieri GM; McDonald MW
Cancer; 1983 Oct; 52(8):1442-7. PubMed ID: 6616407
[TBL] [Abstract][Full Text] [Related]
34. Early morning hydroxyproline excretion in patients with breast cancer.
Powles TJ; Rosset G; Leese CL; Bondy PK
Cancer; 1976 Dec; 38(6):2564-6. PubMed ID: 1000483
[TBL] [Abstract][Full Text] [Related]
35. [Detection of bone metastases using hydroxyproline excretion].
Knorr A; Engelmann U; Gross C; Friedrich S
Radiobiol Radiother (Berl); 1986; 27(1):31-4. PubMed ID: 3704125
[No Abstract] [Full Text] [Related]
36. Circadian rhythm of total urinary hydroxyproline excretion and 3-H hydroxyproline test.
Radom S; Zulawski M; Dahlig E
Clin Chim Acta; 1972 Jun; 39(1):277-8. PubMed ID: 4556834
[No Abstract] [Full Text] [Related]
37. [Urinary pyrophosphate and hydroxyproline in bone tumors].
Maeda H
Nihon Seikeigeka Gakkai Zasshi; 1969 Dec; 43(11):1075-85. PubMed ID: 4314548
[No Abstract] [Full Text] [Related]
38. Urinary hydroxyproline and prognosis in human breast cancer.
Grant CS; Hoare SA; Millis RR; Hayward JL; Wang DY
Br J Surg; 1984 Feb; 71(2):105-8. PubMed ID: 6692099
[TBL] [Abstract][Full Text] [Related]
39. Studies on urinary hydroxyproline.
Ogane S
Fukushima J Med Sci; 1969 May; 15(3):97-109. PubMed ID: 5262427
[No Abstract] [Full Text] [Related]
40. [Value of the determination of urinary hydroxyproline in the detection of bone metastases].
Sanz Ortiz J; Mayo Suárez J; Riancho Moral JA; Amado Señarís JA
Med Clin (Barc); 1983 Sep; 81(7):296-8. PubMed ID: 6645671
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
